LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...
(RTTNews) - Cochlear Limited has received FDA approval in September for the company's Cochlear Remote Assist solution in the Nucleus and Baha Systems. Cochlear noted that the FDA approval for the ...
Hear ye, hear ye: Patients using Cochlear’s hearing implants can now undergo routine adjustments and receive virtual counseling from their hearing health providers completely virtually via Cochlear’s ...
The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology Experience the full interactive ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear Limited is conducting a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback